{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T04:42:58Z","timestamp":1778992978301,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.semarthrit.2021.11.013","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T03:16:04Z","timestamp":1640834164000},"page":"151947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Erosive arthritis autoantibodies in systemic sclerosis"],"prefix":"10.1016","volume":"52","author":[{"given":"Antonella","family":"Riccardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Martinroche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Contin-Bordes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Avouac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Gobeaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Cauvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Guerini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Elise","family":"Truchetet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2021.11.013_bib0001","series-title":"Kelley's textbook of rheumatology","first-page":"1311","article-title":"Systemic sclerosis and the scleroderma-spectrum disorders","author":"Varga","year":"2009"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0002","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.autrev.2013.05.002","article-title":"Systemic sclerosis at the crossroad of polyautoimmunity","volume":"12","author":"Elhai","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0003","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/rheumatology\/kes041","article-title":"Articular involvement in systemic sclerosis","volume":"51","author":"Avouac","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0004","first-page":"591","article-title":"Overview of osteo-articular involvement in systemic sclerosis: specific risk factors, clinico-sonographic evaluation, and comparison with healthy women from the French OFELY cohort. Best practice & research","volume":"32","author":"Thietart","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/archinte.1954.00250020082005","article-title":"Roentgenography changes observed in generalized scleroderma: report of sixty three cases","volume":"94","author":"Boyd","year":"1954","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0006","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/ard.41.2.147","article-title":"The articular manifestations of progressive systemic sclerosis (scleroderma)","volume":"41","author":"Baron","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0007","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.2005.044602","article-title":"Radiological hand involvement in systemic sclerosis","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0008","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s10067-006-0313-3","article-title":"Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis","volume":"26","author":"Ingegnoli","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0009","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jbspin.2007.07.017","article-title":"The \u2018sclerodermic hand\u2019: a radiological and clinical study","volume":"75","author":"Erre","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.semarthrit.2010.06.008","article-title":"Hand radiological damage in systemic sclerosis: comparison with a control group and clinical and functional correlations","volume":"40","author":"Koutaissoff","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0011","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1136\/ard.2011.153734","article-title":"Rheumatoid arthritis near remission: clinical rather than laboratory inflammation is associated with radiographic progression","volume":"70","author":"Aletaha","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0012","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1002\/art.39299","article-title":"IgG subclass specificity discriminates restricted IgM rheumatoid factor responses from more mature anti-citrullinated protein antibody-associated or isotype-switched IgA responses","volume":"67","author":"Falkenburg","year":"2015","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0013","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0014","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/art.24716","volume":"60","author":"van der Linden","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0015","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/ard.2009.116384","article-title":"The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis","volume":"69","author":"van der Woude","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0016","article-title":"An overview of autoantibodies in rheumatoid arthritis","volume":"110","author":"van Delfta","year":"2020","journal-title":"J autoimmun"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0017","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1002\/art.40237","article-title":"F\u00e9d\u00e9ration Hospitalo-Universitaire ACRONIM. Association of the presence of anti-carbamylated protein antibodies in early arthritis with a poorer clinical and radiologic outcome: data from the French ESPOIR Cohort","volume":"69","author":"Truchetet","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0018","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3899\/jrheum.140767","article-title":"Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis","volume":"42","author":"Gan","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0019","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0020","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR scleroderma trials and research Group database","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0021","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1002\/art.40237","article-title":"F\u00e9d\u00e9ration Hospitalo-Universitaire ACRONIM. Association of the presence of anti-carbamylated protein antibodies in early arthritis with a poorer clinical and radiologic outcome: data from the French ESPOIR Cohort","volume":"69","author":"Truchetet","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0022","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/096228029900800102","article-title":"Multiple imputation: a primer","volume":"8","author":"Schafer","year":"1999","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0023","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0024","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/annrheumdis-2014-205295","article-title":"EUSTAR collaborators*; EUSTAR collaborators. Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study","volume":"75","author":"Avouac","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0025","first-page":"20","article-title":"Prevalence of anti-CCP antibodies in systemic sclerosis","volume":"59","author":"Marrone","year":"2007","journal-title":"Reumatismo"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0026","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/rheumatology\/keq205","article-title":"Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis","volume":"49","author":"Ueda-Hayakawa","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0027","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/acr.21668","article-title":"Ultrasonographic hand features in systemic sclerosis and correlates with clinical, biologic and radiographic findings","volume":"64","author":"Elhai","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0028","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-008-8073-2","article-title":"Prevalence of autoantibodies to cyclic cit-rullinated peptide in patients with rheumatic diseases other than rheumatoidarthritis: a French multicenter study","volume":"34","author":"Fabien","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0029","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/rheumatology\/keu022","article-title":"Clinical usefulness of measuring red blood cell distribution width in patients with systemic sclerosis","volume":"53","author":"Farkas","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0030","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/kep138","article-title":"Anti-hnRNP and other autoantibodies in systemic sclerosis with joint involvement","volume":"48","author":"Generini","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0031","first-page":"542","article-title":"Anti-cyclic citrullinated peptide antibody insystemic sclerosis","volume":"26","author":"Morita","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0032","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10067-011-1930-z","article-title":"Anti-cyclic citrullinated peptide anti-bodies in scleroderma patients","volume":"31","author":"Polimeni","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0033","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10067-007-0656-4","article-title":"A comparison of the frequency of anti-bodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis","volume":"27","author":"Santiago","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0034","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2298\/SARH1206350S","article-title":"The clinical significance of antibody determination to cyclic citrullinated peptides in systemic sclerosis","volume":"140","author":"Stamenkovic","year":"2012","journal-title":"Srp ArhCelok Lek"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02686081","article-title":"Increased prevalence of anti-third generation cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and CREST syndrome","volume":"32","author":"Wu","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0036","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/1756-185X.13330","article-title":"Significance of combined anti-CCP antibodies and rheumatoid factor in a New Zealand cohort of patients with systemic sclerosis","volume":"21","author":"Kamalaksha","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0037","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.17219\/acem\/69921","article-title":"Anti-CCP antibodies and rheumatoid factor in systemic sclerosis: prevalence and relationships with joint manifestations","volume":"27","author":"Wielosz","year":"2018","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0038","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/annrheumdis-2018-214816","article-title":"Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study","volume":"78","author":"Elhai","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0039","doi-asserted-by":"crossref","first-page":"341","DOI":"10.31138\/mjr.31.3.341","article-title":"Association of musculoskeletal and radiological features with clinical and serological findings in systemic sclerosis: a single-centre registry study","volume":"31","author":"Azarbani","year":"2020","journal-title":"Mediterr J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jbspin.2017.11.006","article-title":"Anti-citrullinated peptides antibodies in systemic sclerosis: meta-analysis of frequency and meaning","volume":"85","author":"Laustriat","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0041","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/rheumatology\/kem021","article-title":"Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity","volume":"46","author":"Szucs","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0042","doi-asserted-by":"crossref","first-page":"e17088","DOI":"10.1097\/MD.0000000000017088","article-title":"High-resolution computed tomography of the lung in patients with rheumatoid arthritis: prevalence of interstitial lung disease involvement and determinants of abnormalities","volume":"98","author":"Salaffi","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0043","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/intimm\/dxaa021","article-title":"Citrullinated fibrinogen is a target of auto-antibodies in interstitial lung disease in mice with collagen-induced arthritis","volume":"32","author":"Sato","year":"2020","journal-title":"Int Immunol"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0044","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1165\/rcmb.2019-0433OC","article-title":"PAD4 deficiency improves bleomycin-induced neutrophil extracellular traps and fibrosis in mouse lung","volume":"63","author":"Suzuki","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/annrheumdis-2020-217230","article-title":"Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)","volume":"80","author":"Spagnolo","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0046","first-page":"89","article-title":"[Endothelial damage and circadian blood pressure profile in rheumatoid arthritis]","volume":"91","author":"Shilkina","year":"2019","journal-title":"Ter Arkh"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0047","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13075-016-1173-0","article-title":"Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases","volume":"18","author":"Pecani","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0048","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0049","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00784-020-03452-9","article-title":"Localisation of citrullinated and carbamylated proteins in inflamed gingival tissues from rheumatoid arthritis patients","volume":"25","author":"Lee","year":"2021","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210023","article-title":"Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: an intriguing association","volume":"13","author":"Favoino","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0051","doi-asserted-by":"crossref","first-page":"18291","DOI":"10.1038\/s41598-019-54817-4","article-title":"Carbamylation and glycation compete for collagen molecular aging in vivo","volume":"9","author":"Nicolas","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.semarthrit.2021.11.013_bib0052","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/annrheumdis-2019-216709","article-title":"Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease","volume":"79","author":"Castellanos-Moreira","year":"2020","journal-title":"Ann Rheum Dis"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221002158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221002158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:08:25Z","timestamp":1758733705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017221002158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":52,"alternative-id":["S0049017221002158"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.11.013","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erosive arthritis autoantibodies in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151947"}}